Fred LeMaistre, MD
Senior Vice President, Sarah Cannon Cancer Institute
Dr. LeMaistre joined Sarah Cannon in 2012, and as senior vice president of Sarah Cannon Cancer Institute, he is responsible for cancer service line for HCA Healthcare. Previously the medical director for Texas Institute of Medicine and Surgery, LeMaistre is board certified in internal medicine and medical oncology, and has published more than 200 manuscripts.
He is a founding member and former president of the Foundation for the Accreditation of Cellular Therapy (FACT) and he established the first community-based BMT program in 1993. LeMaistre previously served as the president of the American Society for Transplantation and Cellular Therapy (ASTCT) and is currently a member of the American Society of Hematology and the American Society for Clinical Oncology. He received his medical degree from Southwestern Medical School in Texas and performed a fellowship in medical oncology at the University of Texas Health Science Center with training in BMT at Fred Hutchinson Cancer Center in Seattle, Wash.